OSU6162 15 mg clinical trials

OSU6162 in Bipolar Depression: An Open-label, Flexible Dose Study (OBID)

This study is looking into a new medication called OSU6162 for people with bipolar depression. It hopes to see if this medicine can help improve symptoms of depression. Participants will take the medicine, and doctors will monitor their mood over a couple of months.